KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Income from Continuing Operations (2016 - 2025)

Pacific Biosciences Of California has reported Income from Continuing Operations over the past 16 years, most recently at 40371000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 40371000.0 for Q4 2025, down 1802.7% from a year ago — trailing twelve months through Dec 2025 was 546376000.0 (down 76.34% YoY), and the annual figure for FY2025 was 546376000.0, down 76.34%.
  • Income from Continuing Operations for Q4 2025 was 40371000.0 at Pacific Biosciences Of California, down from 38000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PACB hit a ceiling of 2371000.0 in Q4 2024 and a floor of 426075000.0 in Q1 2025.
  • Median Income from Continuing Operations over the past 5 years was 69833000.0 (2023), compared with a mean of 85431578.95.
  • Biggest five-year swings in Income from Continuing Operations: soared 102.89% in 2024 and later crashed 1802.7% in 2025.
  • Pacific Biosciences Of California's Income from Continuing Operations stood at 69329000.0 in 2021, then dropped by 21.72% to 84384000.0 in 2022, then rose by 2.8% to 82018000.0 in 2023, then soared by 102.89% to 2371000.0 in 2024, then crashed by 1802.7% to 40371000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 40371000.0 (Q4 2025), 38000000.0 (Q3 2025), and 41930000.0 (Q2 2025) per Business Quant data.